4C LABS4C LABS is streamlining the way patients access medical cannabis.
The therapeutic potential of cannabis is increasingly becoming public knowledge – supported by decades of research and new regulatory reforms.
Despite the growing support of cannabis as an alternative medicine, surveys have shown that 1.4+ million people across the UK are still relying on illicit cannabis to treat chronic health conditions.
* Medical conditions for which medical cannabis is frequently prescribed
8.5M
Cases of anxiety disorder reported in the UK
Mental Health Foundation
8M
Individuals suffering from chronic pain in the UK
bmj open
1.5M
Reported cases of fibromyalgia in the UK
Fibromyalgia action uk
850K
Individuals with dementia in the UK
Alzheimer’s society
<500K
Reported cases of epilepsy in the UK
Epilepsy society uk
400K
Individuals suffering from rheumatoid arthritis in the UK
bmj open
360K
Reported cases of cancer in the UK
cancer research
145K
Individuals suffering from Parkinson’s Disorder in the UK
Alzheimer’s society
bmj open
With the UK medical cannabis market still in its infancy, there is significant opportunity for ethical companies to solve the most pressing pain points: supply chain challenges, effective products and improved prescription processes. That’s where 4C LABS comes in.
We’re streamlining and simplifying the medical cannabis ecosystem through every step of the supply chain.
guernsey
Our GMP-certified facility and distribution centre are strategically located in close proximity to the UK
united kingdom
Our user-friendly telehealth clinic provides a fast and seamless process from first click to prescription delivery
united kingdom
Our proprietary framework and highly-targeted Step System product line simplifies the prescription process